Was Joseph Samuels’s Islet Management Right About These 5 Stocks?

1. Colfax Corporation (NYSE:CFX)

Islet Management’s Stake Value: $74,230,000   

Stock performance over the past 12 months through November 27: -28%

Colfax Corporation (NYSE:CFX) is a diversified technology corporation involved in the creation and supply of state-of-the-art medical devices and services targeted towards improving orthopedic mobility and performance through DJO Global Inc. DJO was acquired by Colfax Corporation (NYSE:CFX) in 2019 and has 12 facilities globally.

The company was mentioned in the Q3 2021 investor letter of Alphyn Capital Management. Here’s what the investment management firm said about Colfax Corporation (NYSE:CFX):

“I discussed my reasons for initiating a starter position in Colfax in the 2021 Q1 letter. In August, Mitch Rales, founder of both Danaher and Colfax, purchased $11.5m of shares on the open market at approximately $46 per share, and I increased our position size soon after.

I continue to believe Colfax’s prospects are attractive over the long term as the company demonstrates its ability to execute. For example, the MedTech business expanded its shoulder/knee line with the acquisition of Mathys, opening the European market to the rest of the company. It also created a new business focused on the fast-growing foot and ankle segment through three further acquisitions. Meanwhile, the ESAB welding business increased EBTIDA margins from 15% to 18% through the application of the Colfax Business System processes.”

You can also take a peek at the 9 Stocks Better than Apple and 10 Best Junior Silver Mining Stocks.

Follow Insider Monkey on Twitter